It is a healthcare private limited company based in New Delhi, Delhi, India, established in 2021.
2021 | New Delhi, Delhi, India | ActiveRuliva Pharmacueticals Private Limited, a active private limited company, was established on 27 August 2021 in New Delhi, Delhi, India. Engaging in human health activities within the healthcare sector, it holds CIN: U85100DL2021PTC385699. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
Its leadership includes Prabhjot Singh Kohli (Director), Harpreet Kaur (Director). Past directors included Prabhjot Singh Kohli, Vishal Anand, Liza Anand. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at E-237,Cabin N0.-2, Lower Ground Floor,, Amar Colony, Lajpat Nagar-4,, New Delhi, Delhi, 110024.
U85100DL2021PTC385699
385699
27 August 2021
₹0.50 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Ruliva Pharmacueticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prabhjot Singh Kohli | Director | 22 Jul 2023 | Current |
| Harpreet Kaur | Director | 22 Jul 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Director | 25 Jul 2023 | Past |
| Pramod Abcsdd | Director | 25 Jul 2023 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ruliva Pharmacueticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Ruliva Pharmacueticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Ruliva Pharmacueticals has a workforce of 0 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ruliva Pharmacueticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ruliva Pharmacueticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Ruliva Pharmacueticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Ruliva Pharmacueticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Progress on Prabhjot Singh Kohli was appointed as a Director was appointed as a Director on 22 Jul 2023 & has been associated with this company since 2 years 5 months . was documented.
The activity Harpreet Kaur was appointed as a Director was appointed as a Director on 22 Jul 2023 & has been associated with this company since 2 years 5 months . was completed.
Progress on Ruliva Pharmacueticals Private Limited was registered on 27 Aug 2021 with Roc Delhi & aged 4 years 4 months as per MCA records. was documented.
The CIN of Ruliva Pharmacueticals Private Limited is U85100DL2021PTC385699.
Ruliva Pharmacueticals Private Limited is headquartered at E-237,Cabin N0.-2, Lower Ground Floor,, Amar Colony, Lajpat Nagar-4,, New Delhi, Delhi, 110024.
Ruliva Pharmacueticals Private Limited was incorporated on 27 August 2021.
The current directors of Ruliva Pharmacueticals Private Limited are
The primary industry of Ruliva Pharmacueticals Private Limited is Healthcare.
Ruliva Pharmacueticals Private Limited is unlisted.
The authorized capital of Ruliva Pharmacueticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX